XHSvsXPHETF Comparison
VS
State Street SPDR S&P Health Care Services ETF (XHS) and State Street SPDR S&P Pharmaceuticals ETF (XPH) belong to the same industry segment: US Health Care. XHS's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, XPH's top sector exposures are Healthcare. Both XHS and XPH have the same Total Expense Ratio (TER) of 0.35%. XHS is up 27% year-to-date (YTD) with +$111M in YTD flows. XPH performs worse with 23.89% YTD performance, and +$296M in YTD flows. Run a side-by-side ETF comparison of XHS and XPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XHS vs XPH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/09/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XHS XPH | -0.81%-1.20% | +13.32%+19.17% | +27.00%+23.89% | +36.60%+46.50% | +58.87%+66.22% | +23.72%+53.06% |
| Flows | XHS XPH | +$12M+$96M | +$99M+$188M | +$111M+$296M | +$114M+$304M | +$72M+$257M | +$11M+$264M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XHS XPH | +17.83%+22.53% | +17.60%+22.55% | +18.29%+20.51% | +21.34%+20.86% |
| Max drawdown | XHS XPH | -4.21%-6.42% | -11.97%-11.78% | -14.46%-23.45% | -29.93%-30.87% |
| Max drawdown duration | XHS XPH | 66d21d | 121d50d | 250d322d | 1477d1452d |
Trading data
XHS | XPH | |
Last sale 9/9/2026 at 7:59 PM | $135.69 | $68.28 |
| Previous close 09/09/2026 | $135.28 | $69.32 |
| Consolidated volume 09/09/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XHS | XPH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/9/2026 at 7:59 PM
Live
Closed
XHS | XPH | |
|---|---|---|
| Last price | $135.69 | $68.28 |
| 1D performance | +0.30% | -1.50% |
| AuM | $221.10 M | $603.27 M |
| E/R | 0.35% | 0.35% |
Characteristics
XHS | XPH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | State Street Investment Management |
| Benchmark | S&P Health Care Services Select Industry Index | S&P Pharmaceuticals Select Industry Index |
| N° of holdings | 60 | 62 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 28, 2011 | June 19, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
XHS
USA
99.96%
Other
0.04%
XPH
USA
89.67%
Other
10.33%
Sectors
XHS
Healthcare
94.85%
Other
5.15%
XPH
Healthcare
92.7%
Other
7.3%
Advertisement
Diversification
XHS
Total weight of top 15 holdings out of 15
31.01%
XPH
Total weight of top 15 holdings out of 15
32.65%
Top 15 holdings
Data as of July 31, 2026
XHS
Tenet Healthcare Corp.
2.53%
NeoGenomics, Inc.
2.22%
PACS Group, Inc.
2.19%
Lifestance Health Group, Inc.
2.18%
U.S. Physical Therapy, Inc.
2.06%
Addus HomeCare Corp.
2.03%
Guardant Health, Inc.
2.03%
Acadia Healthcare Co., Inc.
2.03%
Chemed Corp.
2.00%
DaVita, Inc.
1.98%
Hinge Health, Inc.
1.97%
Progyny, Inc.
1.97%
GeneDx Holdings Corp.
1.96%
Concentra Group Holdings Parent, Inc.
1.95%
National HealthCare Corp.
1.93%
XPH
Crinetics Pharmaceuticals, Inc.
3.69%
MBX Biosciences, Inc.
3.22%
Amylyx Pharmaceuticals, Inc.
2.29%
Enliven Therapeutics, Inc.
2.24%
Corcept Therapeutics, Inc.
2.22%
Alumis, Inc.
2.13%
Nuvation Bio, Inc.
2.09%
Trevi Therapeutics, Inc.
2.06%
Liquidia Corp.
1.95%
Nektar Therapeutics
1.89%
Amneal Pharmaceuticals, Inc.
1.81%
Bristol Myers Squibb Co.
1.78%
Edgewise Therapeutics, Inc.
1.77%
Omeros Corp.
1.76%
Ligand Pharmaceuticals, Inc.
1.75%
Frequently asked questions about XHS and XPH
How have the XHS and XPH ETFs performed in 2026?
As of September 9, 2026, XHS is up 27% year-to-date (YTD), while XPH has returned 23.89%. That puts XHS better performer ahead so far this year.
Which ETF is attracting more investor money: XHS or XPH?
Year-to-date, the XHS ETF saw +$111M in flows, compared to +$296M for XPH.
Which ETF is more volatile: XHS or XPH?
Over the past year, XHS had a volatility of 17.6%, while XPH experienced 22.55%.
Which ETF is bigger: XHS or XPH?
As of September 9, 2026, XHS holds $221.10 M in assets under management (AUM), while XPH manages $603.27 M.
What sectors do the XHS and XPH ETFs invest in?
XHS leans toward sectors like Healthcare. Meanwhile, XPH focuses on Healthcare.
What are the top holdings of the XHS ETF and XPH ETF?
XHS top holdings include Tenet Healthcare Corp., NeoGenomics, Inc. and PACS Group, Inc.. XPH holds in its top three: Crinetics Pharmaceuticals, Inc., MBX Biosciences, Inc. and Amylyx Pharmaceuticals, Inc..
Which ETF is more diversified: XHS or XPH?
XHS holds 60 securities with 31.01% of its assets in the top 15. XPH has 63 securities and a top 15 weight of 32.65%.
Advertisement
Latest news about XHS & XPH
Donald Trump’s Executive Orders: ETF Bulls and Bears
January 24, 2025
XPH
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
November 20, 2023
XPH
Advertisement
Advertisement
